Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epadel for AF Prevention in Acute Heart Failure and Myocardial Infarction
NCT00692718Phase 4Unknown
- Sponsor
- Osaka General Medical Center
- Start
- Jul 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
Phase 4 trial of eicosapentaenoic acid in Atrial fibrillation (AFib), sponsored by Osaka General Medical Center. Primary endpoint: Atrial fibrillation detection. Status: unknown.
02
Drugs
eicosapentaenoic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00692718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00692718.